title: [Advances of medical treatment of human hydatidosis].
abstract: The Authors report the current trends in chemotherapy of human hydatid disease, on the basis of their own experience, concerning the medical treatment of 425 patients affected by hydatid disease. The Authors describe the factors that can influence the outcome of chemotherapy, such as: the drugs used and their posology, the age of the cysts and/or of the patients, cyst's morphology and localization.
authors.affiliation: Dipartimento di Malattie Infettive e Tropicali, Università La Sapienza, Roma.
authors.forename: F
authors.initials: F
authors.lastname: De Rosa
authors.forename: M G
authors.initials: MG
authors.lastname: Lastilla
authors.forename: C
authors.initials: C
authors.lastname: Franchi
authors.forename: A
authors.initials: A
authors.lastname: Teggi
mesh_terms: D015766:Albendazole / Q000627:therapeutic use*; D000977:Antiparasitic Agents / Q000627:therapeutic use*; D004443:Echinococcosis / Q000188:drug therapy*; D006801:Humans; D008463:Mebendazole / Q000627:therapeutic use*
chemical_list: D000977:Antiparasitic Agents; D008463:Mebendazole; D015766:Albendazole
vernacular_title: Progressi nella terapia medica della idatidosi umana.